This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Thomas Roberts, DPhil
Senior Research Scientist, Research Fellow and Gro at University of Oxford

Profile

Thomas Roberts is a Senior Research Scientist at the Department of Paediatrics, University of Oxford and a Research Fellow at the newly-formed Institute for Developmental and Regenerative Medicine (IDRM). His group works under the overall general theme of ‘RNA Medicine’, with research interests including neuromuscular disorders, RNA biology, extracellular nucleic acids, biomarkers, epigenetics, and gene/oligonucleotide therapies. He studied at the University of Oxford for both his undergraduate degree in Molecular and Cellular Biochemistry and doctoral degree in Physiology, Anatomy and Genetics. He subsequently moved to San Diego, California where he undertook postdoctoral training positions at the Scripps Research Institute, Department of Molecular and Experimental Medicine (laboratory of Professors Kevin Morris and Marc Weinberg) and Sanford Burnham Prebys Medical Discovery Institute, Development, Aging and Regeneration Program (laboratory of Professor Lorenzo Puri).

Agenda Sessions

  • Oligonucleotide Therapeutics for Duchenne Muscular Dystrophy: Current Developments and Competition from Alternative Approaches

    11:00